How P21 Peptide is Revolutionizing Anti-Aging Research

The P21 peptide, derived from the CDK inhibitor p21, is vital in cell cycle regulation, particularly in inhibiting cyclin-dependent kinases. It has therapeutic potential in oncology and regenerative medicine, offering avenues for cancer treatment by inducing apoptosis in cancer cells and enhancing tissue repair by controlling cell growth and differentiation.

General Overview : What is LL-37 peptide

LL-37 is a key antimicrobial peptide in the human immune system, part of the cathelicidin family, derived from hCAP18. Expressed in neutrophils and epithelial cells, it combats infections by neutralizing bacteria, viruses, and fungi. LL-37 also modulates inflammation and aids in wound healing, making it a focus for therapeutic applications.

Left Menu Icon